期刊
VIRCHOWS ARCHIV
卷 479, 期 3, 页码 459-469出版社
SPRINGER
DOI: 10.1007/s00428-021-03059-9
关键词
Colorectal cancer; Tumor budding; Delphi study; ITBCC
类别
资金
- Dutch Cancer Society [10602/2016-2]
An international group of experts reached consensus on a standardized method for tumor budding assessment and reporting, which has been validated and included in international colorectal cancer pathology and clinical guidelines.
Tumor budding is a long-established independent adverse prognostic marker in colorectal cancer, yet methods for its assessment have varied widely. In an effort to standardize its reporting, a group of experts met in Bern, Switzerland, in 2016 to reach consensus on a single, international, evidence-based method for tumor budding assessment and reporting (International Tumor Budding Consensus Conference [ITBCC]). Tumor budding assessment using the ITBCC criteria has been validated in large cohorts of cancer patients and incorporated into several international colorectal cancer pathology and clinical guidelines. With the wider reporting of tumor budding, new issues have emerged that require further clarification. To better inform researchers and health-care professionals on these issues, an international group of experts in gastrointestinal pathology participated in a modified Delphi process to generate consensus and highlight areas requiring further research. This effort serves to re-affirm the importance of tumor budding in colorectal cancer and support its continued use in routine clinical practice.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据